Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffe...
Rallybio Corporation (NASDAQ:RLYB) Sees Significant Decline in Short Interest
Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders?
15:21 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB
Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?
Lixte Biotechnology Shifts Strategy to AI Energy Infrastructure
<![CDATA[Pharma M&A Roundup: Servier Acquiring Edgewise Therapeutics' Muscular Dystrophy Business, Hanmi Enters Licensing Agreement with Eli Lilly, Avenzo Enters Merger Agreement with Rallybio]]>